Are retinal arteriolar abnormalities related to atherosclerosis? The atherosclerosis risk in communities study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1644-1650

  Klein, Ronald ^a,e   Sharrett, A Richey ^b   Klein, Barbara E K ^a   Chambless, Lloyd E ^c   Cooper, Lawton S ^b   Hubbard, Larry D ^a   Evans, Greg ^d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c IL   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Arteriosclerosis; Atherosclerosis; Epidemiology; Inflammation; Risk factors

Indexed keywords

ADULT; AGED; ARTERIOLE; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; RETINA BLOOD VESSEL OCCLUSION; RISK ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0034041507     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1644     Document Type: Article

References (56)

1. Gunn M On ophthalmoscopic evidence of general arterial disease. Trans Opthal Soc UK. 1898;18:356-381.
2. Friedenwald H. The Doyne Memorial Lecture: pathological changes on the retinal blood-vessels in arterio-sclerosis and hypertension. Trans Opthal Soc UK. 1930;50:452-531.
3. Wagener HP, Clay GE, Gipner JF. Classification of retinal lesions in the presence of vascular hypertension. Trans Am Opthalmol Soc. 1947;45:57-73.
4. Leishman R. The eye in general vascular disease: hypertension and arteriosclerosis Br J Ophthalmol. 1957;41:641-701.
5. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol. 1953;49:117-138.
6. Walsh JB. Hypertensive retinopathy: description, classification, and prognosis. Ophthalmology. 1982;89:1127-1131.
7. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939;197:332-343.
8. Aurell E, Tibblin G. Hypertensive eye-ground changes in a Swedish population of middle-aged men. Acta Ophthalmol Scand. 1965;43:355-361.
9. Svardsudd K, Wedel H, Aurell E, Tibblin G. Hypertensive eye ground changes: prevalence, relation to blood pressure and prognostic importance: the study of men born in 1913. Acta Med Scand. 1978;204:159-167.
10. Klein R. Retinopathy in a population-based study. Trans Am Ophthalmol Soc. 1992;90:561-594.
11. Klein R, Klein BEK, Moss SE, Wang Q. Blood pressrue hypertension, and retinopathy in a population. Trans Am Ophthalmol Soc. 1993;91:207-226.
12. Klein R, Klein BEK, Moss SE. The relation of systematic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1997;95:329-350.
13. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, Pinsky JL, Klein R. Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1999;150:263-270.
14. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA. 1997;277:1689-1695.
15. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129: 687-702.
16. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, Shahar E, Kalsbeek W. Differences between respondents and nonrespondents in a multi-center community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49:1441-1446.
17. Shahar E, Folsom AR, Jackson R, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Ann Epidemiol. 1996;6:498-506.
18. Atherosclerosis Risk in Communities (ARIC) Study Research Group. ARIC Retinal Photography Protocol, Manual 14A/ARIC Retinal Reading Center Protocol, Manual 14B. Chapel Hill, NC: ARIC Coordinating Center, Department of Biostatistics (CSCC), University of North Carolina, Chapel Hill; CB No. 8030.
19. National Heart, Lung, and Blood Institute. Atherosclerosis Risk in Communities Study, Operations Manual No. 2: Cohort Component Procedures, Version 2.0. Chapel Hill, NC: ARIC Coordinating Center, School of Public Health, University of North Carolina, Chapel Hill; 1988.
20. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R, Cooper LS, Sharrett AR, Davis MD, Cai J, and the Atherosclerosis Risk in Communities (ARIC) Study Group. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities (ARIC) Study. Ophthalmology. 1999; 106:2269-2280.
21. Parr JC, Spears GFS. General caliber of the retinal arteries expressed as the equivalent width of the central retinal artery. Am J Ophthalmol. 1974;77:472-477.
22. Parr JC, Spears GFS. Mathematic relationships between the width of a retinal artery and the widths of its branches. Am J Ophthalmol. 1974;77: 478-483.
23. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1:68-73.
24. Riley WA, Barnes RW, Bond MG, Evans G, Chambless LE, Heiss G. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimaging. 1991;1: 168-172.
25. Duncan BB, Metcalf P, Crouse JR III, Li R, Sharrett AR, Tegeler C, Tyroler HA, Heiss G. Risk factors differ for carotid artery plaque with and without acoustic shadowing: Atherosclerosis Risk in Communities Study Investigators. J Neuroimaging. 1997;7:28-34.
26. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995; 26:386-391.
27. Demirovic J, Nabulsi A, Folsom AR, Carpenter MA, Szklo M, Sorlie PD, Barnes RW. Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1993;88: 2787-2793.
28. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results: experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994;118: 496-500.
29. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25:66-73.
30. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134:250-256.
31. Howard G, Burke GL, Szklo M, Tell GS, Eckfeldt J, Evans G, Heiss G. Active and passive smoking are associated with increased carotid wall thickness: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277-1282.
32. Li R, Duncan BB, Metcalf PA, Crouse JR III, Sharrett AR, Tyroler HA, Barnes R, Heiss G. B-mode-detected carotid artery plaque in a general population: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25:2377-2383.
33. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997:16:149-162.
34. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136:525-537.
35. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine: results from the 'Clue' Study and the ARIC Study. JAMA. 1993;269:488-493.
36. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1994:14:1098-1104.
37. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102-1108.
38. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I: development of blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-19.
39. Atherosclerosis Risk in Communities Study, Manual 9: Hemostasis Determinations. Chapel Hill, NC: National Heart, Lung, and Blood Institute, National Institutes of Health, Collaborative Studies Coordinating Center, University of North Carolina; 1987.
40. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
41. Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. Short-term intraindividual variability in hemostasis factors: the ARIC Study. Ann Epidemiol. 1992;2:723-733.
42. Wilcovsky TC, Chambless LE. A comparison of direct adjustment and regression adjustment of epidemiologic measures. J Chronic Dis. 1985; 38:849-856.
43. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1985.
44. Friedewald J. Retinal arteriosclerosis: arteriosclerosis. In: Cowdry EV, ed. A Survey of the Problem. New York, NY: MacMillan Co; 1993:363-395.
45. Duke-Elder S, Dobree JH. Diseases of the retina. In: Duke-Elder S, ed. System of Ophthalmology. St Louis, Mo: CV Mosby Co; 1967:315-337.
46. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
47. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
48. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 1998;41:1241-1248.
49. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:1359-1362.
50. Kessler L, Wiesel ML, Attali P, Mossard J, Cazenave JP, Finget M. von Willebrand factor in diabetic angiopathy. Diabetes Metab. 1998;24:327-336.
51. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993;70:380-385.
52. Aoki N. Epidemiological evaluation of funduscopic findings in cerebrovascular diseases, II: a multivariate analysis of funduscopic findings. Jpn Circ J. 1975:39:271-282.
53. Stokoe NL. Fundus changes in hypertension: a long-term clinical study. In: JS Cant, ed. The William Mackenzie Centenary Symposium on the Ocular Circulation in Health and Disease. St Louis, Mo: CV Mosby Co: 1969:117-135.
54. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, Dobs A, Evans GW, Heiss G. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 1997;131:115-125.
55. Shelburne SA. Retinal arteriovenous nicking: a long-term study of the development of arteriovenous nicking in hypertensive patients. Arch Intern Med. 1949;83:377-381.
56. Ralph RA. Prediction of cardiovascular status from arteriovenous crossing phenomena. Ann Ophthalmol. 1974;6:323-326.